RA Capital Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,999,997
| Closed | -$2.14M | – | 90 |
|
|
2024
Q3 | $2.14M | Sell |
1,999,997
-3,551,298
| -64% | -$3.8M | 0.02% | 79 |
|
|
2024
Q2 | $11.9M | Hold |
5,551,295
| – | – | 0.16% | 61 |
|
|
2024
Q1 | $18M | Hold |
5,551,295
| – | – | 0.23% | 65 |
|
|
2023
Q4 | $114M | Hold |
5,551,295
| – | – | 1.78% | 14 |
|
|
2023
Q3 | $89.3M | Buy |
5,551,295
+1,777,778
| +47% | +$28.6M | 1.76% | 16 |
|
|
2023
Q2 | $32.1M | Hold |
3,773,517
| – | – | 0.61% | 40 |
|
|
2023
Q1 | $37.2M | Hold |
3,773,517
| – | – | 0.84% | 36 |
|
|
2022
Q4 | $36M | Hold |
3,773,517
| – | – | 0.73% | 37 |
|
|
2022
Q3 | $65.6M | Buy |
3,773,517
+25,128
| +0.7% | +$437K | 1.4% | 23 |
|
|
2022
Q2 | $29.1M | Buy |
3,748,389
+81,726
| +2% | +$633K | 0.77% | 37 |
|
|
2022
Q1 | $55.3M | Buy |
+3,666,663
| New | +$55.3M | 1.21% | 24 |
|